Glenvale Packaging introduces MultiPharma V10 in the UK

Published: 25-Aug-2011
Manufacturing

An automatic capsule filling machine that handles potent products

A new, automatic capsule filling system produced by Italian manufacturer MultiPharma is now available exclusively in the UK from Glenvale Packaging.

The MultiPharma V10 system is the first new machine to be introduced into the UK since Northamptonshire-based Glenvale Packaging was appointed to distribute MultiPharma’s products.

The totally enclosed V10 system is suitable for handling potent products and can process up to 9,000 capsules/hr. It has a footprint of 90x110cm and, owing to fitted castors, can be moved around a production facility.

‘The design is ideal for handling hard shell capsules – both gelatine and vegetarian options,’ said Garry Coleman, partner at Glenvale Packaging.

‘It is supplied fully specified to handle the desired capsule size. Additional accessories can then also be fitted to accommodate size changes as needed.’

The unit only requires air and electrical connections and is operated by a touchscreen that can be positioned to suit the operator’s needs. The anodised, aluminium construction meets GMP regulatory requirements.

‘The V10 has already been proven in Europe,’ added Coleman. ‘It is suited to a range of applications – from clinical trials in the health industry through to small manufacturing operations.’

See more

You may also like

Manufacturing

Glenvale Packaging makes inroads into Europe

Read more
Successful installation for a specialist manufacturing chemist in Slovenia removes potential bottlenecks between production and filling operations

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
  3. Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
  4. Lonza delivers strong performance in Q1 2026 in line with expectations and confirms full-year Outlook 2026 Basel, Switzerland, 8 May 2026 – In its qualitative Q1 2026 business update, Lonza1 reported a strong performance across its CDMO business in line with the expected trajectory for Full-Year 2026. As expected, due to a lower prior year base, campaign timing and product releases, and planned site shutdowns, CER sales growth and CORE EBITDA margin will be notably stronger in the first half of 2026 than in the second half
  5. Piramal Pharma Solutions unveils state-of-the-art payload-linker suite at its Riverview, Michigan facility The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialised solutions for payload-linkers. This cutting-edge suite will significantly enhance the company’s ability to support global payload-linker development and manufacturing and help partners bring complex therapies like antibody-drug conjugates (ADCs) and other bioconjugates to market

Upcoming event

Cleanroom Technology Conference UK

20-21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Glenvale Packaging makes inroads into Europe

Successful installation for a specialist manufacturing chemist in Slovenia removes potential bottlenecks between production and filling operations
Manufacturing

Glenvale Packaging offers Yener tooling in UK

Press tools, parts, maintenance kits and storage boxes are all included in the agreement
Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Subscribe now